NCT05924165View on ClinicalTrials.gov

Narcotic-Free Percutaneous Nephrolithotomy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions
Nephrolithiasis
Interventions
DRUG

5mg Oxycodone, Q6 PRN

Oxycodone is an opioid that is used to relieve moderate to severe pain.

DRUG

10mg Ketorolac, Q6 PRN

Ketorolac is an NSAID used to relieve moderately severe pain.

Trial Locations (1)

10019

Mount Sinai West, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05924165 - Narcotic-Free Percutaneous Nephrolithotomy | Biotech Hunter | Biotech Hunter